Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Prostatic Neoplasms: HELP
Florence Joly
Based on 20 articles published since 2008
||||
Expertise Level
The expertise of Florence Joly ranks in the
  • Top 0.81%
  • ... of 138,005 published authors worldwide on Prostatic Neoplasms
  • ... from 2008 through 2019
  • ... based on contributions to 20 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Aliases Joly, F   ·   Joly, Florence
Work Locations
Details
Most likely:    Miscellaneous institutions in Caen      
2018
  • Department of Cancer Medicine, Gustave Roussy, Université Paris-Saclay, Villejuif, France. · Institut Paoli Calmette, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Marseille University, UM 105, F-13284, Marseille, France. · Department of Clinical Research and Investigation, Biostatistics and Methodology Unit, Institut Gustave Roussy, Villejuif, France. · Oncology Department, Centre François Baclesse, Caen, France. · Oncology Department, European Georges Pompidou Hospital, René Descartes University, Paris, France. · Department of Oncology, Centre hospitalier départemental Les Oudairies, La Roche-sur-Yon, France. · Department of Radiotherapy, Groupe ONCORAD Garonne and Clinique Pasteur, Toulouse, France. · Department of Oncology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France. · Department of Urology, Andrology and Transplantation, Centre Hospitalier Universitaire Toulouse-Rangueil, Toulouse, France. · Department of Medical Oncology, Paul Papin Cancer Centre, Angers, France. · Department of Oncology, Centre Bergonié, Bordeaux, France. · Department of Medical Oncology, Centre Eugène Marquis, Rennes, France. · Department of Medical Oncology, Hopital Foch, Suresnes, France. · Department of Medical Oncology, Antoine Lacassagne Cancer Centre, Nice, France. · Department of Medical Oncology, Curie Institute, Paris, France. · R&D Unicancer, Paris, France. · Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Saint Herblain, France. · Department of Medical Oncology, Hopital Riviera-Chablais, Vaud-Valais - Vevey, Switzerland. · Department of Medical Oncology, Institut Claudius Rigaud, Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France. · Medical Oncology Department, Centre Georges-François Leclerc, Dijon, France. · Medical Oncology Department, Clinique Sainte Marguerite, Hyeres, France. · Medical Oncology Department, Hôpital Layné, Mont de Marsan, France. · Medical Oncology Department, Centre Hospitalier La Timone, Marseille, France. · Medical Oncology Department, Centre Régional Hospitalier, Metz-Thionville, France. · Medical Oncology Department, Hôpital Bretonneau, Tours, France. · Medical Oncology Department, Centre Hospitalier Dupuytren, Limoges, France. · Institut Roi Albert II, Service d'Oncologie Médicale, Cliniques Universitaires Saint-Luc and Institut de Recherche Clinique et Expérimentale (Pole MIRO), Université Catholique de Louvain, Brussels, Belgium. · Medical Oncology Department, Centre Catherine de Sienne, Nantes, France. · Medical Oncology Department, Hôpital Saint-André, Bordeaux, France. · Medical Oncology Department, Clinique Saint-Jean Languedoc, Toulouse, France. · Medical Oncology Department, Institut Jean Godinot, Reims, France. · Medical Oncology Department, Clinique Armoricaine de Radiologie, Saint Brieuc, France. · Medical Oncology Department, Hôpital Avicenne, Bobigny, France. · Medical Oncology Department, Hôpital Saint Louis, Paris, France. · Department of Clinical Research and Investigation, Biostatistics, and Methodology Unit, Institut Paoli Calmettes, Marseille, France. · Department of Cancer Medicine, Gustave Roussy, Université Paris-Saclay, Villejuif, France. Electronic address: · Pubmed 29074061
  • Centre de Recherche en Cancerologie de Marseille (CRCM), Institut Paoli-Calmettes, Aix-Marseille University, Marseille, France. Electronic address: · Biostatistic, Institut Paoli-Calmettes, Aix-Marseille Universite, Marseille, France. · Dana-Farber Cancer Institute, ECOG-ACRIN Biostatistics Center, Boston, MA, USA. · University of Wisconsin Carbone Cancer Center, Madison, WI, USA. · Gustave Roussy, University of Paris Sud, Villejuif, France. · Johns Hopkins University, Baltimore, MD, USA. · Department of Medical Oncology, Hopital Europeen Georges Pompidou, Paris, France. · Centre Francois Baclesse, Caen, France. · Centre Hospitalier Universitaire Rangueil, Toulouse, France. · UNICANCER, Paris, France. · University of Virginia, Charlottesville, VA, USA. · Cleveland Clinic Foundation, Cleveland, OH, USA. · University of Michigan Comprehensive Cancer, Ann Arbor, MI, USA. · Mayo Clinic, Rochester, MN, USA. · Nevada Cancer Research Foundation, Las Vegas, NV, USA. · Washington University School of Medicine, St. Louis, MO, USA. · University of Kentucky College of Medicine, Lexington, KY, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Pubmed 29475737
2017
  • OHSU Knight Cancer Institute, Portland, OR, USA. Electronic address: · Juravinski Cancer Centre, Hamilton, ON, Canada. · Centre Hospitalier de l'Université de Montréal, Institut du Cancer de Montréal, Montréal, QC, Canada. · P A Herzen Moscow Cancer Research Institute, Ministry of Healthcare of the Russian Federation, Moscow, Russia. · N N Blokhin Cancer Research Center, Ministry of Healthcare of the Russian Federation, Moscow, Russia. · Centre Leon Berard, Lyon, France. · Institute Paoli-Calmettes, Marseille, France. · Centre François Baclesse, Caen, France. · University of British Columbia, BC Cancer Agency-Vancouver Centre, Vancouver, BC, Canada. · The Clatterbridge Cancer Centre, Bebington, UK. · Trial Architecture Consulting, Washington, DC, USA. · OncoGenex Pharmaceuticals, Bothell, WA, USA. · Gustave Roussy, University of Paris Saclay, Villejuif, France. · Pubmed 29033099
  • SESSTIM, Institut Paoli-Calmettes, Marseille, France; Aix-Marseille Université, INSERM, IRD, SESSTIM, Marseille, France. Electronic address: · Biostatistic, Institut Paoli-Calmettes, Marseille, France. · Medical Oncology, Centre François Baclesse - CHU Côte de Nacre, Caen, France. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris-Sud, Villejuif, France. · Medical Oncology Department, Georges Pompidou Hospital, Rene Descartes University, Paris, France. · Medical Oncology, Hôpital Saint-Louis, Paris, France. · UNICANCER, Paris, France. · Aix-Marseille Université, INSERM, IRD, SESSTIM, Marseille, France; Biostatistic, Institut Paoli-Calmettes, Marseille, France. · Medical Oncology, Institut Paoli-Calmettes, Marseille, France. · Pubmed 28780479
2016
  • Medical Oncology, Institut Paoli-Calmettes, Marseille, France. Electronic address: · Biostatistics, Institut Paoli-Calmettes, Marseille, France; Aix-Marseille Université, UMR_S 912 (SESSTIM), IRD, Marseille, France; INSERM, UMR_S 912 (SESSTIM), Marseille, France. · Medical Oncology, Centre François Baclesse - CHU Côte de Nacre, Caen, France. · Urology Department, Centre Hospitalier Universitaire Rangueil, Toulouse, France. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Medical Oncology, Centre Hospitalier Les Oudairies, La Roche-sur-Yon, France. · Radiotherapy Department, Clinique Pasteur, Toulouse, France. · Department of Medical Oncology, Centre Paul Papin, Angers, France. · Medical Oncology, Centre Alexis Vautrin, Vandoeuvre-les-Nancy, France. · Medical Oncology, Centre Eugène Marquis, Rennes, France. · Medical Oncology, Centre René Gauducheau, Saint-Herblain, France. · Medical Oncology, Hôpital Foch, Suresnes, France. · Medical Oncology, Groupe Hospitalier Saint Joseph, Paris, France. · Medical Oncology, Centre Antoine Lacassagne, Nice, France. · Medical Oncology, Hôpital Saint-Louis, Paris, France. · Institut Claudius Régaud, Toulouse, France. · Medical Oncology, Institut Curie, Paris, France. · UNICANCER, Paris, France. · Medical Oncology Department, Georges Pompidou Hospital and René Descartes University, Paris, France. · Pubmed 26610858
2015
  • Medical Oncology Department, Institut Paoli-Calmettes, Marseille, France. Electronic address: · Biostatistics Department, Institut Paoli-Calmettes, and Aix-Marseille Université, UMR_S 912 (SESSTIM), Marseille, France. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Medical Oncology Department, Centre François Baclesse-CHU Côte de Nacre, Caen, France. · Medical Oncology Department, Centre Hospitalier Les Oudairies, La Roche-sur-Yon, France. · Institut Paoli-Calmettes, and Aix-Marseille Université, UMR_S912 (SESSTIM), Marseille, France. · Radiotherapy Department, Clinique Pasteur, Toulouse, France. · Department of Medical Oncology, Centre Paul Papin, Angers, France. · Medical Oncology Department, Centre Alexis Vautrin, Vandoeuvre-les-Nancy, France. · Medical Oncology Department, Centre Eugène Marquis, Rennes, France. · Surgical Urology Department, Institut Paoli-Calmettes, Marseille, France. · Medical Oncology Department, Centre René Gauducheau, Saint-Herblain, France. · Medical Oncology Department, Hôpital Foch, Suresnes, France. · Medical Oncology Department, Groupe Hospitalier Saint Joseph, Paris, France. · Medical Oncology Department, Centre Antoine Lacassagne, Nice, France. · Medical Oncology Department, Centre Val d'Aurelle-Paul Lamarque, Montpellier, France. · Medical Oncology Department, Institut Claudius Régaud, Toulouse, France. · Medical Oncology Department, Institut Curie, Paris, France. · Medical Oncology Department, Centre Georges François Leclerc, Dijon, France. · R&D UNICANCER, Paris cedex 13, France. · Medical Oncology Department, Clinique Sainte Marguerite, Hyeres, France. · Medical Oncology Department, Hôpital Layné, Mont de Marsan, France. · Medical Oncology Department, Centre Hospitalier La Timone, Marseille, France. · Medical Oncology Department, Centre Régional Hospitalier, Metz-Thionville, France. · Medical Oncology Department, Hôpital Bretonneau, Tours, France. · Medical Oncology Department, Centre Hospitalier Dupuytren, Limoges, France. · Medical Oncology Department, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium. · Medical Oncology Department, Centre Catherine de Sienne, Nantes, France. · Medical Oncology Department, Hôpital Saint-André, Bordeaux, France. · Medical Oncology Department, Clinique Saint-Jean Languedoc, Toulouse, France. · Medical Oncology Department, Institut Jean Godinot, Reims, France. · Medical Oncology Department, Clinique Armoricaine de Radiologie, Saint-Brieux, France. · Medical Oncology Department, Hôpital Saint-Louis, Paris, France. · Urology Department, Centre Hospitalier Universitaire Rangueil, Toulouse, France. · Medical Oncology Department, Georges Pompidou Hospital and Rene Descartes University, Paris, France. · Pubmed 25277272
2014
  • Department of Medical Oncology, Nimes University Hospital, Nimes, France; · Clinical Research and Clinical Epidemiology Unit, Bergonié Cancer Institute, Bordeaux, France; · Department of Oncology, Claudius Régaud Cancer Center, Toulouse, France; · Department of Medical Oncology, François Baclesse Cancer Center, Caen, France; · Department of Medical Oncology, Antoine Lacassagne Cancer Center, Nice, France; · Department of Medical Oncology, CHD La Roche sur Yon, La Roche sur Yon, France; · Alienor Farma, Parc Scientifique Unitec 1, Pessac, France; · Centre Hospitalier de Pellegrin, Laboratoire de Pharmacologie et Toxicologie, Bordeaux, France; · INSERM U862, Neurocentre Magendie, Bordeaux, France. · Pubmed 25355844
  • Medical Oncology, Institut Paoli-Calmettes, Marseille, France. Electronic address: · Institut Paoli-Calmettes, Marseilles, France; Inserm, UMR 912 'Economic & Social Sciences, Health Systems & Societies (SESSTIM)', Aix-Marseille Université, IRD, Marseilles, France. · Medical Oncology, Centre François Baclesse - CHU Côte de Nacre, Caen, France. · Medical Oncology Department, Georges Pompidou Hospital and Rene Descartes University, Paris, France. · Medical Oncology, Centre Hospitalier Les Oudairies, La Roche-sur-Yon, France. · Biostatistic, Institut Paoli-Calmettes, Marseille, France. · Radiotherapy Department, Clinique Pasteur, Toulouse, France. · Department of Medical Oncology, Centre Paul Papin, Angers, France. · Medical Oncology, Centre Alexis Vautrin, Vandoeuvre-les-nancy, France. · Medical Oncology, Centre Eugène Marquis, Rennes, France. · Medical Oncology, Centre René Gauducheau, Saint-Herblain, France. · Medical Oncology, Hôpital Foch, Suresnes, France. · Medical Oncology, Groupe Hospitalier Saint Joseph, Paris, France. · Medical Oncology, Centre Antoine Lacassagne, Nice, France. · Medical Oncology, Centre Val d'Aurelle-Paul Lamarque, Montpellier, France. · Medical Oncology, Institut Claudius Régaud, Toulouse, France. · Medical Oncology, Institut Curie, Paris, France. · Medical Oncology, Centre Georges François Leclerc, Dijon, France. · R&D UNICANCER, Paris cedex 13, France. · Medical Oncology, Clinique Sainte Marguerite, Hyeres, France. · Medical Oncology, Hôpital Layné, Mont de Marsan, France. · Medical Oncology, Centre Hospitalier La Timone, Marseille, France. · Medical Oncology, Centre Régional Hospitalier, Metz-Thionville, France. · Medical Oncology, Hôpital Bretonneau, Tours, France. · Medical Oncology, Centre Hospitalier Dupuytren, Limoges, France. · Medical Oncology, Cliniques Universitaires Saint-Luc, Université catholique de Louvain, Bruxelles, Belgium. · Medical Oncology, Centre Catherine de Sienne, Nantes, France. · Medical Oncology, Hôpital Saint-André, Bordeaux, France. · Medical Oncology, Clinique Saint-Jean Languedoc, Toulouse, France. · Medical Oncology, Institut Jean Godinot, Reims, France. · Medical Oncology, Clinique armoricaine de radiologie, Saint-Brieux, France. · Medical Oncology, Hôpital Saint-Louis, Paris, France. · Urology Department, Centre Hospitalier Universitaire Rangueil, Toulouse, France. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 24424105
2010
  • Service d'Oncologie Médicale, CLCC François-Baclesse, 3 avenue du Général-Harris, 14076 Caen cedex, France. · Pubmed 20728393
2016
  • aNuclear Medicine Department bBiostatistics and Clinical Research Unit Departments of cMedical Oncology dRadiation Oncology eUro-Oncology Multidisciplinary Staff Meeting, François Baclesse Cancer Centre fNormandie University gNuclear Medicine Department, University Hospital, Caen, France. · Pubmed 26642435
2012
  • CLCC François-Baclesse, service de recherche clinique, Caen, France. · Pubmed 22877855
Probable:    INSERM France      
2016
  • French National Quality of Life in Oncology Platform, Besançon, France. · Methodology and Quality of Life in Oncology Unit, University Hospital of Besançon, Besançon, France. · EA3181, University of Franche-Comté, Besançon, France. · Service biostatistiques et information médicale (DIM), University Hospital of Dijon, Dijon, France. · INSERM, CIC 1432, Centre d'investigation clinique, University Hospital of Dijon, Dijon, France. · INSERM UMR 1181 Biostatistiques, Biomathématiques, Pharmacoépidemiologie et Maladies infectieuses (B2PHI), University of Burgundy Franche-Comté, Dijon, France. · Department of Radiation Oncology, Georges François Leclerc Cancer Center, Dijon, France. · Université Pierre et Marie Curie, Paris, France. · Department of Medical Oncology, Centre François Baclesse, Inserm U1086, Caen, France. · EA3181, University of Franche-Comté, Besançon, France. · Registre général des tumeurs du Calvados, Cancers & Préventions - U 1086 Inserm - UCBN, Centre François Baclesse, Caen, France. · Department of Urology, University Hospital of Besançon, Besançon, France. · French National Quality of Life in Oncology Platform, Besançon, France. · Registre des Cancers du Bas-Rhin, Strasbourg, France. · Pubmed 27923377
  • Calvados General Tumor Registry, François Baclesse Cancer Center, Caen, France. Electronic address: · Calvados General Tumor Registry, François Baclesse Cancer Center, Caen, France; UMR 1086 « Cancers et Préventions », Inserm - University of Basse-Normandie, Caen, France. · Tarn Cancer Registry, Albi, France; Claudius Regaud Institute, IUCT-O, Tarn Cancer Registry, Toulouse, France. · UMR 1086 « Cancers et Préventions », Inserm - University of Basse-Normandie, Caen, France; Quality of Life in Oncology National Platform, France. · EA 3181, SFR-FED 4234, University of Franche Comté, France. · Claudius Regaud Institute, IUCT-O, Tarn Cancer Registry, Toulouse, France. · UMR 1086 « Cancers et Préventions », Inserm - University of Basse-Normandie, Caen, France; Department of Medical Oncology, François Baclesse Cancer Center, Caen, France; CHU Côte de Nacre, University of Basse-Normandie, Caen, France. · Pubmed 27318002
Probable:    Universite de Caen Normandie      
2015
  • Medical Oncology-Clinical Research Department, Centre François Baclesse - CHU Côte de Nacre, Caen, France; Universite Basse Normandie, Caen, France. · Pubmed 24180479
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 20 total) written by Florence Joly about Prostatic Neoplasms:

  • Anticancer Activity and Tolerance of Treatments Received Beyond Progression in Men Treated Upfront with Androgen Deprivation Therapy With or Without Docetaxel for Metastatic Castration-naïve Prostate Cancer in the GETUG-AFU 15 Phase 3 Trial. 2018
  • Burden of Metastatic Castrate Naive Prostate Cancer Patients, to Identify Men More Likely to Benefit from Early Docetaxel: Further Analyses of CHAARTED and GETUG-AFU15 Studies. 2018
  • Custirsen (OGX-011) combined with cabazitaxel and prednisone versus cabazitaxel and prednisone alone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (AFFINITY): a randomised, open-label, international, phase 3 trial. 2017
  • Q-TWiST analysis of patients with metastatic castrate naive prostate cancer treated by androgen deprivation therapy with or without docetaxel in the randomised phase III GETUG-AFU 15 trial. 2017
  • Cross-cultural adaptation and validation of the French version of the Expanded Prostate cancer Index Composite questionnaire for health-related quality of life in prostate cancer patients. 2016
  • Long-term quality of life among localised prostate cancer survivors: QALIPRO population-based study. 2016
  • Pairwise comparison of 18F-FDG and 18F-FCH PET/CT in prostate cancer patients with rising PSA and known or suspected second malignancy. 2016
  • Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival Analysis of the Randomized Phase 3 GETUG-AFU15 Trial. 2016
  • Prognostic Factors for Survival in Noncastrate Metastatic Prostate Cancer: Validation of the Glass Model and Development of a Novel Simplified Prognostic Model. 2015
  • Clinical benefits of non-taxane chemotherapies in unselected patients with symptomatic metastatic castration-resistant prostate cancer after docetaxel: the GETUG-P02 study. 2015
Show List of Full Article Records
Google Searches

Learn more about Florence Joly using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Miscellaneous institutions in Caen
INSERM France
Universite de Caen Normandie
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Miscellaneous institutions in Caen
2018
  • Department of Cancer Medicine, Gustave Roussy, Université Paris-Saclay, Villejuif, France. · Institut Paoli Calmette, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Marseille University, UM 105, F-13284, Marseille, France. · Department of Clinical Research and Investigation, Biostatistics and Methodology Unit, Institut Gustave Roussy, Villejuif, France. · Oncology Department, Centre François Baclesse, Caen, France. · Oncology Department, European Georges Pompidou Hospital, René Descartes University, Paris, France. · Department of Oncology, Centre hospitalier départemental Les Oudairies, La Roche-sur-Yon, France. · Department of Radiotherapy, Groupe ONCORAD Garonne and Clinique Pasteur, Toulouse, France. · Department of Oncology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France. · Department of Urology, Andrology and Transplantation, Centre Hospitalier Universitaire Toulouse-Rangueil, Toulouse, France. · Department of Medical Oncology, Paul Papin Cancer Centre, Angers, France. · Department of Oncology, Centre Bergonié, Bordeaux, France. · Department of Medical Oncology, Centre Eugène Marquis, Rennes, France. · Department of Medical Oncology, Hopital Foch, Suresnes, France. · Department of Medical Oncology, Antoine Lacassagne Cancer Centre, Nice, France. · Department of Medical Oncology, Curie Institute, Paris, France. · R&D Unicancer, Paris, France. · Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Saint Herblain, France. · Department of Medical Oncology, Hopital Riviera-Chablais, Vaud-Valais - Vevey, Switzerland. · Department of Medical Oncology, Institut Claudius Rigaud, Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France. · Medical Oncology Department, Centre Georges-François Leclerc, Dijon, France. · Medical Oncology Department, Clinique Sainte Marguerite, Hyeres, France. · Medical Oncology Department, Hôpital Layné, Mont de Marsan, France. · Medical Oncology Department, Centre Hospitalier La Timone, Marseille, France. · Medical Oncology Department, Centre Régional Hospitalier, Metz-Thionville, France. · Medical Oncology Department, Hôpital Bretonneau, Tours, France. · Medical Oncology Department, Centre Hospitalier Dupuytren, Limoges, France. · Institut Roi Albert II, Service d'Oncologie Médicale, Cliniques Universitaires Saint-Luc and Institut de Recherche Clinique et Expérimentale (Pole MIRO), Université Catholique de Louvain, Brussels, Belgium. · Medical Oncology Department, Centre Catherine de Sienne, Nantes, France. · Medical Oncology Department, Hôpital Saint-André, Bordeaux, France. · Medical Oncology Department, Clinique Saint-Jean Languedoc, Toulouse, France. · Medical Oncology Department, Institut Jean Godinot, Reims, France. · Medical Oncology Department, Clinique Armoricaine de Radiologie, Saint Brieuc, France. · Medical Oncology Department, Hôpital Avicenne, Bobigny, France. · Medical Oncology Department, Hôpital Saint Louis, Paris, France. · Department of Clinical Research and Investigation, Biostatistics, and Methodology Unit, Institut Paoli Calmettes, Marseille, France. · Department of Cancer Medicine, Gustave Roussy, Université Paris-Saclay, Villejuif, France. Electronic address: · Pubmed 29074061
  • Centre de Recherche en Cancerologie de Marseille (CRCM), Institut Paoli-Calmettes, Aix-Marseille University, Marseille, France. Electronic address: · Biostatistic, Institut Paoli-Calmettes, Aix-Marseille Universite, Marseille, France. · Dana-Farber Cancer Institute, ECOG-ACRIN Biostatistics Center, Boston, MA, USA. · University of Wisconsin Carbone Cancer Center, Madison, WI, USA. · Gustave Roussy, University of Paris Sud, Villejuif, France. · Johns Hopkins University, Baltimore, MD, USA. · Department of Medical Oncology, Hopital Europeen Georges Pompidou, Paris, France. · Centre Francois Baclesse, Caen, France. · Centre Hospitalier Universitaire Rangueil, Toulouse, France. · UNICANCER, Paris, France. · University of Virginia, Charlottesville, VA, USA. · Cleveland Clinic Foundation, Cleveland, OH, USA. · University of Michigan Comprehensive Cancer, Ann Arbor, MI, USA. · Mayo Clinic, Rochester, MN, USA. · Nevada Cancer Research Foundation, Las Vegas, NV, USA. · Washington University School of Medicine, St. Louis, MO, USA. · University of Kentucky College of Medicine, Lexington, KY, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Pubmed 29475737
2017
  • OHSU Knight Cancer Institute, Portland, OR, USA. Electronic address: · Juravinski Cancer Centre, Hamilton, ON, Canada. · Centre Hospitalier de l'Université de Montréal, Institut du Cancer de Montréal, Montréal, QC, Canada. · P A Herzen Moscow Cancer Research Institute, Ministry of Healthcare of the Russian Federation, Moscow, Russia. · N N Blokhin Cancer Research Center, Ministry of Healthcare of the Russian Federation, Moscow, Russia. · Centre Leon Berard, Lyon, France. · Institute Paoli-Calmettes, Marseille, France. · Centre François Baclesse, Caen, France. · University of British Columbia, BC Cancer Agency-Vancouver Centre, Vancouver, BC, Canada. · The Clatterbridge Cancer Centre, Bebington, UK. · Trial Architecture Consulting, Washington, DC, USA. · OncoGenex Pharmaceuticals, Bothell, WA, USA. · Gustave Roussy, University of Paris Saclay, Villejuif, France. · Pubmed 29033099
  • SESSTIM, Institut Paoli-Calmettes, Marseille, France; Aix-Marseille Université, INSERM, IRD, SESSTIM, Marseille, France. Electronic address: · Biostatistic, Institut Paoli-Calmettes, Marseille, France. · Medical Oncology, Centre François Baclesse - CHU Côte de Nacre, Caen, France. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris-Sud, Villejuif, France. · Medical Oncology Department, Georges Pompidou Hospital, Rene Descartes University, Paris, France. · Medical Oncology, Hôpital Saint-Louis, Paris, France. · UNICANCER, Paris, France. · Aix-Marseille Université, INSERM, IRD, SESSTIM, Marseille, France; Biostatistic, Institut Paoli-Calmettes, Marseille, France. · Medical Oncology, Institut Paoli-Calmettes, Marseille, France. · Pubmed 28780479
2016
  • Medical Oncology, Institut Paoli-Calmettes, Marseille, France. Electronic address: · Biostatistics, Institut Paoli-Calmettes, Marseille, France; Aix-Marseille Université, UMR_S 912 (SESSTIM), IRD, Marseille, France; INSERM, UMR_S 912 (SESSTIM), Marseille, France. · Medical Oncology, Centre François Baclesse - CHU Côte de Nacre, Caen, France. · Urology Department, Centre Hospitalier Universitaire Rangueil, Toulouse, France. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Medical Oncology, Centre Hospitalier Les Oudairies, La Roche-sur-Yon, France. · Radiotherapy Department, Clinique Pasteur, Toulouse, France. · Department of Medical Oncology, Centre Paul Papin, Angers, France. · Medical Oncology, Centre Alexis Vautrin, Vandoeuvre-les-Nancy, France. · Medical Oncology, Centre Eugène Marquis, Rennes, France. · Medical Oncology, Centre René Gauducheau, Saint-Herblain, France. · Medical Oncology, Hôpital Foch, Suresnes, France. · Medical Oncology, Groupe Hospitalier Saint Joseph, Paris, France. · Medical Oncology, Centre Antoine Lacassagne, Nice, France. · Medical Oncology, Hôpital Saint-Louis, Paris, France. · Institut Claudius Régaud, Toulouse, France. · Medical Oncology, Institut Curie, Paris, France. · UNICANCER, Paris, France. · Medical Oncology Department, Georges Pompidou Hospital and René Descartes University, Paris, France. · Pubmed 26610858
2015
  • Medical Oncology Department, Institut Paoli-Calmettes, Marseille, France. Electronic address: · Biostatistics Department, Institut Paoli-Calmettes, and Aix-Marseille Université, UMR_S 912 (SESSTIM), Marseille, France. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Medical Oncology Department, Centre François Baclesse-CHU Côte de Nacre, Caen, France. · Medical Oncology Department, Centre Hospitalier Les Oudairies, La Roche-sur-Yon, France. · Institut Paoli-Calmettes, and Aix-Marseille Université, UMR_S912 (SESSTIM), Marseille, France. · Radiotherapy Department, Clinique Pasteur, Toulouse, France. · Department of Medical Oncology, Centre Paul Papin, Angers, France. · Medical Oncology Department, Centre Alexis Vautrin, Vandoeuvre-les-Nancy, France. · Medical Oncology Department, Centre Eugène Marquis, Rennes, France. · Surgical Urology Department, Institut Paoli-Calmettes, Marseille, France. · Medical Oncology Department, Centre René Gauducheau, Saint-Herblain, France. · Medical Oncology Department, Hôpital Foch, Suresnes, France. · Medical Oncology Department, Groupe Hospitalier Saint Joseph, Paris, France. · Medical Oncology Department, Centre Antoine Lacassagne, Nice, France. · Medical Oncology Department, Centre Val d'Aurelle-Paul Lamarque, Montpellier, France. · Medical Oncology Department, Institut Claudius Régaud, Toulouse, France. · Medical Oncology Department, Institut Curie, Paris, France. · Medical Oncology Department, Centre Georges François Leclerc, Dijon, France. · R&D UNICANCER, Paris cedex 13, France. · Medical Oncology Department, Clinique Sainte Marguerite, Hyeres, France. · Medical Oncology Department, Hôpital Layné, Mont de Marsan, France. · Medical Oncology Department, Centre Hospitalier La Timone, Marseille, France. · Medical Oncology Department, Centre Régional Hospitalier, Metz-Thionville, France. · Medical Oncology Department, Hôpital Bretonneau, Tours, France. · Medical Oncology Department, Centre Hospitalier Dupuytren, Limoges, France. · Medical Oncology Department, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium. · Medical Oncology Department, Centre Catherine de Sienne, Nantes, France. · Medical Oncology Department, Hôpital Saint-André, Bordeaux, France. · Medical Oncology Department, Clinique Saint-Jean Languedoc, Toulouse, France. · Medical Oncology Department, Institut Jean Godinot, Reims, France. · Medical Oncology Department, Clinique Armoricaine de Radiologie, Saint-Brieux, France. · Medical Oncology Department, Hôpital Saint-Louis, Paris, France. · Urology Department, Centre Hospitalier Universitaire Rangueil, Toulouse, France. · Medical Oncology Department, Georges Pompidou Hospital and Rene Descartes University, Paris, France. · Pubmed 25277272
2014
  • Department of Medical Oncology, Nimes University Hospital, Nimes, France; · Clinical Research and Clinical Epidemiology Unit, Bergonié Cancer Institute, Bordeaux, France; · Department of Oncology, Claudius Régaud Cancer Center, Toulouse, France; · Department of Medical Oncology, François Baclesse Cancer Center, Caen, France; · Department of Medical Oncology, Antoine Lacassagne Cancer Center, Nice, France; · Department of Medical Oncology, CHD La Roche sur Yon, La Roche sur Yon, France; · Alienor Farma, Parc Scientifique Unitec 1, Pessac, France; · Centre Hospitalier de Pellegrin, Laboratoire de Pharmacologie et Toxicologie, Bordeaux, France; · INSERM U862, Neurocentre Magendie, Bordeaux, France. · Pubmed 25355844
  • Medical Oncology, Institut Paoli-Calmettes, Marseille, France. Electronic address: · Institut Paoli-Calmettes, Marseilles, France; Inserm, UMR 912 'Economic & Social Sciences, Health Systems & Societies (SESSTIM)', Aix-Marseille Université, IRD, Marseilles, France. · Medical Oncology, Centre François Baclesse - CHU Côte de Nacre, Caen, France. · Medical Oncology Department, Georges Pompidou Hospital and Rene Descartes University, Paris, France. · Medical Oncology, Centre Hospitalier Les Oudairies, La Roche-sur-Yon, France. · Biostatistic, Institut Paoli-Calmettes, Marseille, France. · Radiotherapy Department, Clinique Pasteur, Toulouse, France. · Department of Medical Oncology, Centre Paul Papin, Angers, France. · Medical Oncology, Centre Alexis Vautrin, Vandoeuvre-les-nancy, France. · Medical Oncology, Centre Eugène Marquis, Rennes, France. · Medical Oncology, Centre René Gauducheau, Saint-Herblain, France. · Medical Oncology, Hôpital Foch, Suresnes, France. · Medical Oncology, Groupe Hospitalier Saint Joseph, Paris, France. · Medical Oncology, Centre Antoine Lacassagne, Nice, France. · Medical Oncology, Centre Val d'Aurelle-Paul Lamarque, Montpellier, France. · Medical Oncology, Institut Claudius Régaud, Toulouse, France. · Medical Oncology, Institut Curie, Paris, France. · Medical Oncology, Centre Georges François Leclerc, Dijon, France. · R&D UNICANCER, Paris cedex 13, France. · Medical Oncology, Clinique Sainte Marguerite, Hyeres, France. · Medical Oncology, Hôpital Layné, Mont de Marsan, France. · Medical Oncology, Centre Hospitalier La Timone, Marseille, France. · Medical Oncology, Centre Régional Hospitalier, Metz-Thionville, France. · Medical Oncology, Hôpital Bretonneau, Tours, France. · Medical Oncology, Centre Hospitalier Dupuytren, Limoges, France. · Medical Oncology, Cliniques Universitaires Saint-Luc, Université catholique de Louvain, Bruxelles, Belgium. · Medical Oncology, Centre Catherine de Sienne, Nantes, France. · Medical Oncology, Hôpital Saint-André, Bordeaux, France. · Medical Oncology, Clinique Saint-Jean Languedoc, Toulouse, France. · Medical Oncology, Institut Jean Godinot, Reims, France. · Medical Oncology, Clinique armoricaine de radiologie, Saint-Brieux, France. · Medical Oncology, Hôpital Saint-Louis, Paris, France. · Urology Department, Centre Hospitalier Universitaire Rangueil, Toulouse, France. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 24424105
2010
  • Service d'Oncologie Médicale, CLCC François-Baclesse, 3 avenue du Général-Harris, 14076 Caen cedex, France. · Pubmed 20728393
2016
  • aNuclear Medicine Department bBiostatistics and Clinical Research Unit Departments of cMedical Oncology dRadiation Oncology eUro-Oncology Multidisciplinary Staff Meeting, François Baclesse Cancer Centre fNormandie University gNuclear Medicine Department, University Hospital, Caen, France. · Pubmed 26642435
2012
  • CLCC François-Baclesse, service de recherche clinique, Caen, France. · Pubmed 22877855
INSERM France
2016
  • French National Quality of Life in Oncology Platform, Besançon, France. · Methodology and Quality of Life in Oncology Unit, University Hospital of Besançon, Besançon, France. · EA3181, University of Franche-Comté, Besançon, France. · Service biostatistiques et information médicale (DIM), University Hospital of Dijon, Dijon, France. · INSERM, CIC 1432, Centre d'investigation clinique, University Hospital of Dijon, Dijon, France. · INSERM UMR 1181 Biostatistiques, Biomathématiques, Pharmacoépidemiologie et Maladies infectieuses (B2PHI), University of Burgundy Franche-Comté, Dijon, France. · Department of Radiation Oncology, Georges François Leclerc Cancer Center, Dijon, France. · Université Pierre et Marie Curie, Paris, France. · Department of Medical Oncology, Centre François Baclesse, Inserm U1086, Caen, France. · EA3181, University of Franche-Comté, Besançon, France. · Registre général des tumeurs du Calvados, Cancers & Préventions - U 1086 Inserm - UCBN, Centre François Baclesse, Caen, France. · Department of Urology, University Hospital of Besançon, Besançon, France. · French National Quality of Life in Oncology Platform, Besançon, France. · Registre des Cancers du Bas-Rhin, Strasbourg, France. · Pubmed 27923377
  • Calvados General Tumor Registry, François Baclesse Cancer Center, Caen, France. Electronic address: · Calvados General Tumor Registry, François Baclesse Cancer Center, Caen, France; UMR 1086 « Cancers et Préventions », Inserm - University of Basse-Normandie, Caen, France. · Tarn Cancer Registry, Albi, France; Claudius Regaud Institute, IUCT-O, Tarn Cancer Registry, Toulouse, France. · UMR 1086 « Cancers et Préventions », Inserm - University of Basse-Normandie, Caen, France; Quality of Life in Oncology National Platform, France. · EA 3181, SFR-FED 4234, University of Franche Comté, France. · Claudius Regaud Institute, IUCT-O, Tarn Cancer Registry, Toulouse, France. · UMR 1086 « Cancers et Préventions », Inserm - University of Basse-Normandie, Caen, France; Department of Medical Oncology, François Baclesse Cancer Center, Caen, France; CHU Côte de Nacre, University of Basse-Normandie, Caen, France. · Pubmed 27318002
Universite de Caen Normandie
2015
  • Medical Oncology-Clinical Research Department, Centre François Baclesse - CHU Côte de Nacre, Caen, France; Universite Basse Normandie, Caen, France. · Pubmed 24180479
6 Other Locations Show
Yearly article counts 022422121310
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.